6.41

2.40% 0.15

After Hours: 6.41

Meiragtx Holdings Plc (MGTX)

Overview News Price History Option Chain Financials Discussions Forecast

Meiragtx Holdings Plc stock is traded at $6.41, with a volume of 398.52K. It is up +2.40% in the last 24 hours and up +4.23% over the past month. MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Previous Close:

$6.26

Open:

$6.35

24h Volume:

398.52K

Relative Volume:

1.18

Market Cap:

$500.96M

Revenue:

$14.02M

Net Income/Loss:

$-84.03M

P/E Ratio:

-4.3605

EPS:

-1.47

Net Cash Flow:

$-125.54M

1W Performance:

+11.09%

1M Performance:

+4.23%

6M Performance:

+45.02%

1Y Performance:

+4.74%

1-Day Range:

$6.14

$6.46

1-Week Range:

$5.66

$6.65

52-Week Range:

$3.85

$7.37

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name

Meiragtx Holdings Plc

Sector

Healthcare (1176)

Industry

Biotechnology (685)

Phone

646-860-7985

Address

450 EAST 29TH STREET, NEW YORK, NY

Employee

389

Twitter

@MeiraGTx

Next Earnings Date

2024-11-12

Latest SEC Filings

MGTX's Discussions on Twitter

Compare MGTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MGTX Meiragtx Holdings Plc	6.41	500.96M	14.02M	-84.03M	-125.54M	-1.47
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-31-24	Resumed	Chardan Capital Markets	Buy
Oct-23-20	Initiated	RBC Capital Mkts	Outperform
Sep-15-20	Resumed	BofA Securities	Buy
Sep-03-19	Initiated	Piper Jaffray	Overweight
Feb-27-19	Reiterated	Chardan Capital Markets	Buy
Jul-03-18	Initiated	Barclays	Overweight
Jul-03-18	Initiated	BofA/Merrill	Buy

View All

Meiragtx Holdings Plc Stock (MGTX) Latest News

Jan 21, 2025

MeiraGTX CFO Richard Giroux sells $150,960 in ordinary shares - Investing.com

Jan 21, 2025

Long Term Trading Analysis for (MGTX) - Stock Traders Daily

Jan 21, 2025

Jan 20, 2025

Is MeiraGTx Holdings plc (MGTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey

Jan 20, 2025

Jan 18, 2025

MeiraGTx (NASDAQ:MGTX) Trading 8% HigherWhat's Next? - MarketBeat

Jan 18, 2025

Jan 17, 2025

Barclays PLC Acquires 76,437 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Jan 17, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Acquired by Barclays PLC - MarketBeat

Jan 17, 2025

Jan 15, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by Jane Street Group LLC - Defense World

Jan 15, 2025

Jan 14, 2025

Contrasting Innate Pharma (OTCMKTS:IPHYF) and MeiraGTx (NASDAQ:MGTX) - Defense World

Jan 14, 2025

Jan 10, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Sells $231,878.33 in Stock - MarketBeat

Jan 10, 2025

MeiraGTX president sells shares worth $305,342 By Investing.com - Investing.com Nigeria

Jan 10, 2025

Head-To-Head Survey: Tevogen Bio (NASDAQ:TVGN) and MeiraGTx (NASDAQ:MGTX) - Defense World

Jan 10, 2025

Jan 09, 2025

Geode Capital Management LLC Cuts Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Jan 09, 2025

Jan 02, 2025

High Growth Tech Stocks in the United States - Simply Wall St

Jan 02, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Holdings Lifted by Barclays PLC - Defense World

Jan 02, 2025

Jan 01, 2025

State Street Corp Boosts Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Jan 01, 2025

Dec 31, 2024

How the (MGTX) price action is used to our Advantage - Stock Traders Daily

Dec 31, 2024

Dec 29, 2024